Trial Outcomes & Findings for Vertebrobasilar Flow Evaluation and Risk of Transient Ischemic Attack and Stroke (VERiTAS) (NCT NCT00590980)
NCT ID: NCT00590980
Last Updated: 2017-11-17
Results Overview
Definite fatal and nonfatal ischemic stroke in the vertebrobasilar territory
Recruitment status
COMPLETED
Target enrollment
82 participants
Primary outcome timeframe
up to 27 months
Results posted on
2017-11-17
Participant Flow
Participant milestones
| Measure |
All Study Participants
Patients with intracranial or extracranial vertebrobasilar occlusion or stenosis ≥ 50% presenting with vertebrobasilar distribution TIA or stroke.
|
|---|---|
|
Overall Study
STARTED
|
82
|
|
Overall Study
COMPLETED
|
72
|
|
Overall Study
NOT COMPLETED
|
10
|
Reasons for withdrawal
| Measure |
All Study Participants
Patients with intracranial or extracranial vertebrobasilar occlusion or stenosis ≥ 50% presenting with vertebrobasilar distribution TIA or stroke.
|
|---|---|
|
Overall Study
Did not meet all inclusion criteria
|
10
|
Baseline Characteristics
Vertebrobasilar Flow Evaluation and Risk of Transient Ischemic Attack and Stroke (VERiTAS)
Baseline characteristics by cohort
| Measure |
Study Participants
n=72 Participants
Patients with intracranial or extracranial vertebrobasilar occlusion or stenosis ≥ 50% presenting with vertebrobasilar distribution TIA or stroke.
|
|---|---|
|
Age, Continuous
|
65.6 years
n=5 Participants
|
|
Sex: Female, Male
Female
|
32 Participants
n=5 Participants
|
|
Sex: Female, Male
Male
|
40 Participants
n=5 Participants
|
|
Ethnicity (NIH/OMB)
Hispanic or Latino
|
8 Participants
n=5 Participants
|
|
Ethnicity (NIH/OMB)
Not Hispanic or Latino
|
64 Participants
n=5 Participants
|
|
Ethnicity (NIH/OMB)
Unknown or Not Reported
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
American Indian or Alaska Native
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Asian
|
4 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Black or African American
|
18 Participants
n=5 Participants
|
|
Race (NIH/OMB)
White
|
49 Participants
n=5 Participants
|
|
Race (NIH/OMB)
More than one race
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Unknown or Not Reported
|
1 Participants
n=5 Participants
|
|
Region of Enrollment
Canada
|
6 participants
n=5 Participants
|
|
Region of Enrollment
United States
|
66 participants
n=5 Participants
|
PRIMARY outcome
Timeframe: up to 27 monthsPopulation: Study participants meeting all inclusion and exclusion criteria
Definite fatal and nonfatal ischemic stroke in the vertebrobasilar territory
Outcome measures
| Measure |
Study Participants
n=72 Participants
Patients with intracranial or extracranial vertebrobasilar occlusion or stenosis ≥ 50% presenting with vertebrobasilar distribution TIA or stroke.
|
|---|---|
|
Fatal and Nonfatal Ischemic Stroke in the Vertebrobasilar Territory
|
72 Participants
|
Adverse Events
Observation
Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Sepideh Amin-Hanjani, MD
University of Illinois at Chicago
Phone: 312-996-4842
Email: [email protected]
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place